Brief: Spectrum Pharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.12
10/11/2022 21:26
Nov 10 (Reuters) - Spectrum Pharmaceuticals Inc
SPPI.O :
* SPECTRUM PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* CASH RUNWAY EXPECTED TO EXTEND THROUGH 2024
* QTRLY LOSS PER SHARE OF $0.12
* Q3 EARNINGS PER SHARE VIEW $-0.15 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw6fzmFga
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary